[The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes]

Zh Nevropatol Psikhiatr Im S S Korsakova. 1973;73(4):530-4.
[Article in Russian]
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Amantadine / administration & dosage
  • Amantadine / adverse effects
  • Amantadine / therapeutic use*
  • Chronic Disease
  • Female
  • Humans
  • Male
  • Middle Aged
  • Parasympatholytics / adverse effects
  • Parasympatholytics / therapeutic use
  • Parkinson Disease / drug therapy*
  • Parkinson Disease, Postencephalitic / drug therapy
  • Parkinson Disease, Secondary / drug therapy
  • Placebos

Substances

  • Parasympatholytics
  • Placebos
  • Amantadine